<DOC>
	<DOCNO>NCT00501345</DOCNO>
	<brief_summary>Primary Objective : To determine risk bleed ASA therapy thrombocytopenic patient develop Acute Coronary Syndrome ( ACS ) , assess effect overall morbidity mortality patient well platelet function .</brief_summary>
	<brief_title>Aspirin Patients With Myocardial Infarction Thrombocytopenia</brief_title>
	<detailed_description>Aspirin known decrease death rate much 50 % patient suffer heart attack . Patients low platelet count give aspirin fear increase risk bleeding . Researchers want compare risk versus benefit use aspirin patient population . Participants study suffer chest pain treat single enteric coat aspirin 325 mg instead current treatment without aspirin . Participants test confirm heart attack EKG ( test measure electrical activity heart ) blood test ( 5ml blood ) drawn every 8 hour detect enzyme release heart due heart attack . Blood sample also examine platelet number . Participants find heart attack platelet count 100,000 20,000 continue aspirin ( 160 mg per day ) . All standard medication heart attack also give . Participants find heart attack whose platelet number 100,000 give standard therapy heart attack , include enteric coat aspirin 325 mg per day , long take part study . Participants find heart attack whose platelet number le 20,000 include study treat deemed appropriate primary physician . Participants examine daily evaluate bleeding . Blood sample ( 30 ml blood ) also draw aspirin give 24 hour , 72 hour 7 day aspirin treatment study platelet function . Participants follow study 7 day . Participants follow cardiology clinic within 1-2 week discharge hospital , month six month . Further follow every 6 month . Patients request follow cardiology phone time bleed . Participants find heart attack receive aspirin treatment . This investigational study . Aspirin FDA approve drug treatment heart attack commercially available . Aspirin standard therapy patient heart attack . Thirty patient take part study . All enrol M. D. Anderson .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>1 . Presenting Cardiology consult M.D . Anderson Cancer Center . 2 . Platelet count 100,000 20,000 . 3 . Acute Coronary Syndrome diagnose first 12 lead EKG . 4 . Patients continue show evidence MI cardiac enzyme CPK level &gt; 2 normal limit , CKMB level 10 % normal limit , Troponin I level &gt; 1.4ug/L consider positive MI . 5 . Ability give consent . 1 . Contraindications aspirin include severe intolerance true allergy , active bleeding , hemophilia , active retinal bleeding , severe untreated hypertension , active peptic ulcer , significant source gastrointestinal genitourinary bleeding , brain metastasis , alter mental status . 2 . Unwillingness inability give consent . 3 . Progressive heart failure , unstable angina respond medical therapy 24 hour , ventricular tachycardia , necessitate thrombolysis , angioplasty . 4 . Patients rule MI cardiac enzyme panel first 24 hour . 5 . Patients rule MI Platelet count &gt; 100,000 . 6 . Patients platelet count &lt; 20,000 .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Thrombocytopenia</keyword>
	<keyword>Platelet Function</keyword>
	<keyword>Acute Coronary Syndrome</keyword>
	<keyword>Myocardial Infarction</keyword>
	<keyword>Heart Attack</keyword>
	<keyword>Aspirin</keyword>
</DOC>